01:47:55 EDT Sat 17 May 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:SVA - SERNOVA BIOTHERAPEUTICS INC - https://www.sernova.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SVA - T  110.00.20·0.2056.00.20-0.01-4.8142.229380.21  0.21  0.200.40  0.1515:30:21May 1415 min RT 2¢
TSX - T110.00.20·0.2056.00.20-0.01-4.8112.523270.21  0.21  0.200.40  0.1515:30:2115 min
Omega - O 0.2124.0520.21  0.21  0.2112:46:3915 min
Chi-X - X 0.205-0.005-2.44.5140.21  0.21  0.20513:05:1915 min
CXD - D 0.210.72    May 0215 min
TriAct - M 0.210.603    Sep 10-2015 min

Recent Trades - Last 10 of 38
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:30:21T0.20-0.0114,0002 RBC1 AnonymousK
13:39:28T0.205-0.0055,50053 Morgan Stanley1 AnonymousK
13:39:28T0.205-0.00550053 Morgan Stanley79 CIBCK
13:39:28T0.205-0.0051,00053 Morgan Stanley1 AnonymousK
13:39:23T0.20-0.015002 RBC79 CIBCK
13:39:23M0.20-0.01902 RBC79 CIBCE
13:36:54T0.20-0.015,0007 TD Sec1 AnonymousK
13:36:54T0.20-0.0110,0002 RBC1 AnonymousK
13:36:54T0.20-0.0115,0002 RBC1 AnonymousK
13:36:54T0.20-0.015,00017 Integral1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-05-14 15:52C:SVA0.21News ReleaseSernova talks interim data from Cell Pouch trial
2025-04-17 17:09C:SVA0.20News ReleaseSernova closes $4-million term loan from Navigate
2025-04-15 18:48C:SVA0.18News ReleaseSernova to highlight Cell Pouch organ at Rome meeting
2025-04-01 17:17C:SVA0.165News ReleaseSernova to continue to Cohort C T1D trial in H2 2025
2025-03-14 16:03C:SVA0.175SEDAR Interim MD & ASEDAR Interim MD & A
2025-03-14 15:58C:SVA0.175SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-03-10 17:13C:SVA0.185News ReleaseSernova appoints Calias as CDO, R&D head
2025-03-05 12:32C:SVA0.19News ReleaseSernova arranges $1-million debenture financing
2025-03-03 19:48C:SVA0.20News ReleaseSernova receives FDA clearance for IND application
2025-02-07 18:04C:SVA0.21Change NameSernova name change to Sernova Biotherapeutics
2025-02-03 18:58C:SVA0.205News ReleaseSernova applies for investigational new drug to FDA
2025-01-30 16:44C:SVA0.21News ReleaseSernova appoints Haghighat as chair
2025-01-13 11:37C:SVA0.225News ReleaseSernova shareholders elect six directors at ASM
2024-12-23 17:34C:SVA0.22SEDAR Annual Information FormSEDAR Annual Information Form
2024-12-23 17:27C:SVA0.22SEDAR MD & ASEDAR MD & A
2024-12-23 17:21C:SVA0.22SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-12-20 16:42C:SVA0.23News ReleaseSernova reschedules AGSM to Jan. 10
2024-12-02 18:35C:SVA0.22News ReleaseSernova enters product development LOI in Saudi Arabia
2024-10-11 09:27C:SVA0.26News ReleaseSernova appoints Parsons as CFO
2024-09-19 09:49C:SVA0.245News ReleaseSernova appoints Paterson to board